newsfilter
← Latest News
GlobeNewswire·

Hepion Pharmaceuticals Receives $3.2 Million in Aggregate Non-Dilutive Funding

EDISON, N.J., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for